Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Nanomedicine. 2015 Dec 17;12(2):309–316. doi: 10.1016/j.nano.2015.11.012

Figure 1.

Figure 1

A schematic illustration of dendrimer critical nanoscale design parameter control and engineering for optimizing prototypes suitable for various nanomedical applications. (i) Size control (approximately 1 nm per generation) with mathematically defined polyvalent surface functionality; (ii) polyvalent dendrimer surface chemistry can be chemically partitioned into imaging groups (A), therapy with cleavable linkers (B), targeting groups (C) and biocompatible or circulatory enhancement groups (Z). Cited from reference2 with permission.